About this event

  • Date and time Fri 8 Jul 2022 from 8:45am to 5:00pm
  • Location Royal Society of Medicine
  • Organised by Urology

Join this meeting that will explore the assessment and treatment of adolescents presenting with gender dysphoria, with evidence for intervention with medical hormonal therapy. We aim to highlight potential issues for clinicians looking after adolescents and future clinical consequences for adults who have undergone early treatment as an adolescent. Also, learn the ethics and legality of treating children.

This meeting is aimed at medical clinicians to discuss the use of gonadotropin-releasing hormone (GnRH) agonists (more commonly known as hormone or puberty blockers) in transgender adolescents. The early use of blockers has been suggested as reversible but as treatment of this group increases, issues and challenges regarding fertility preservation and the effects of future gender reassignment surgery, cognitive and bone health have been highlighted.

This meeting will provide a balanced and informed discussion of the current practice affecting medical practitioners from urology, gynaecology, endocrinology and psychiatry looking after adolescents with gender incongruence.

Topics include:

  • The evidence for medical intervention in adolescent dysphoria
  • Highlight and understand the controversies in this area
  • Ethics and legality of treating children
  • The roles of all gender identity specialists in adolescent dysphoria
  • Provide a template for future research and management in this challenging area

*Please note we will need to check all GMC numbers of attendees to this meeting. Ensure you bring this with you, attendance may be denied otherwise. 

The Urology Section would like to thank our Annual Sponsor KARL STORZ Endoscopy (UK) Ltd for their valued support of the entire 2021 to 2022 Academic Programme.

Please note that the scientific programme and content have not been influenced in any way by the sponsors.

Follow us on:




View the programme

Registration, tea and coffee
Welcome and introduction

Professor Seshadri Sriprasad, President, Urology Section, Royal Society of Medicine

Session 1: Background to treatment

Chair: Dr Abdul Lakhdar, Consultant Endocrinologist, Barts Health NHS Trust


Miss Pippa Sangster, Consultant Urological Surgeon and Andrologist, University College London Hospital NHS Foundation Trust and Mr Roland Morley, Consultant Urologist, Imperial College Healthcare NHS Trust

Assessment of childhood dysphoria

Dr Polly Carmichael, Consultant Clinical Psychologist, The Tavistock and Portman NHS Foundation Trust

Endocrine intervention in adolescents

Professor Gary Butler, Professor of Paediatric Endocrinology, University College London Hospitals NHS Foundation Trust

Assessment of gender dysphoria in adults

Professor Christina Richards, Lead Consultant Psychologist, The Tavistock and Portman NHS Foundation Trust

Endocrine intervention in adults

Dr Peter Hammond, Consultant Physician, Harrogate and District NHS Foundation Trust

Panel discussion

Session 2

Chair: Professor Seshadri Sriprasad

Uncertain ethics: Ethical principles around novel or controversial treatment for children and adolescents

Professor Dominic Wilkinson, Professor of Medical Ethics, University of Oxford

What convinces the medical profession that interventions work

Professor Susan Bewley, Professor of Women's Health, King’s College London

Consenting to medical treatment: Assessment of competence and capacity - what the law says

Dr Peter Dunne, Senior Lecturer, University of Bristol Law School

Panel discussion

Session 3: Implications of early treatment

Chair: Professor Henrietta Bowden-Jones OBE, President and Council Member, Psychiatry Section, Royal Society of Medicine

Fertility, the context of regulation

Dr Melanie Davies, Consultant Obstetrician and Gynaecologist, University College London Hospitals NHS Foundation Trust

Fertility preservation birth registered female

Dr Sania Latif, Clinical Research Fellow, University College London Hospitals NHS Foundation Trust

Fertility preservation birth registered male

Miss Pippa Sangster

Adult fertility - can you go back after blockers and hormones

Dr Channa Jayasena, Reader and Consultant in Reproductive Endocrinology, Imperial College London

Panel discussion
Tea and coffee break

Session 4: Penile inversion in primary surgery

Chair: Mr James Bellringer, Consultant Surgeon, Parkside Private Hospital

Debate: Penile inversion should be the standard for primary surgery

Miss Tina Rashid, Consultant Urological Surgeon, Imperial College Healthcare NHS Trust (for) and Professor Mark-Bram Bouman, Plastic Reconstructive Gender Surgeon, Vrije University Amsterdam (against)

Session 5: How we go forward

Chair: Mr Roland Morley

Panel discussion: How we go forward

Dr Polly Carmichael, Miss Pippa Sangster, Professor Melanie Davies, Professor Susan Bewley and Dr Peter Dunne

Closing remarks
Close of meeting
Drinks reception



Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom

Man searching computer

Join the RSM and get free access to digital learning resources

The RSM has an extensive digital learning and online e-resources platform. As a member you'll enjoy free access to a wealth of online  resources, including 5,000 subscription and open access e-journals, 2,000 e-books and 5 key medical databases, to support your clinical decision-making and research.

Become a member

Disclaimer: All views expressed at this event are of the speakers themselves and not of the RSM nor the speaker's organisations.

Registration for this event will close at 1:00am on 7 July 2022. Late registrations will not be accepted.